Xenogen's real-time in vivo imaging and transgenic technologies can improve success rates in drug discovery and development in pharmaceutical and biotechnology R&D
Xenogen is now Caliper Life Sciences. By combining with Caliper, we have formed a new company with a unique suite of proprietary molecular imaging, microfluidics and automation technologies. Our products and services help our customers bridge in vitro and in vivo experimentation and enhance the clinical relevance of drug discovery and development. Learn more at www.caliperLS.com.
Xenogen is a leading biotechnology company and developer of in vivo biophotonic technology, which allows real-time, non-invasive exploration of genes, proteins, pathogens, and tumor cells in living animals. Xenogen offers a complement of patented biophotonic and fluorescent imaging technologies, as well as genetically modified animal programs. Product lines include imaging systems, biological reagents, specialized light producing animal models, and genetic modification programs for pharmaceutical and biotechnology research and development.